Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.
Arcadia Biosciences Inc (NASDAQ: RKDA) pioneers agricultural biotechnology to develop sustainable crop solutions and plant-based food ingredients. This dedicated news hub provides investors and industry stakeholders with verified updates on the company’s advancements in nutritional science and farming innovations.
Access official press releases covering financial results, product launches like GoodWheat™ ingredients, and strategic partnerships. Our curated collection includes updates on crop trait licensing agreements, sustainability initiatives, and technological breakthroughs in hemp and soy improvement.
Bookmark this page for real-time updates on RKDA’s progress in enhancing food quality through science-driven solutions while promoting resource-efficient agriculture. Discover how Arcadia’s dual focus on consumer nutrition and farm productivity shapes the future of sustainable food systems.
GoodWheat™ pasta has achieved the American Heart Association's Heart-Check mark for its five varieties, marking a significant step towards healthier eating. Each serving contains 8g of fiber and 9g of protein, providing four times the fiber of traditional pasta. This certification underscores GoodWheat's compliance with strict nutritional standards, emphasizing high fiber, low sodium, and zero saturated fat. Cultivated by Arcadia Biosciences (Nasdaq: RKDA), GoodWheat is Non-GMO Project verified and sourced from USA farms. It is currently available in over 1,000 retail locations and on Amazon.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced that its GoodWheat™ pasta is now available in over 1,000 retail locations, doubling its distribution since the launch in June 2022. The pasta offers significant health benefits, containing four times the fiber and 25% more protein than traditional pasta. CEO Stan Jacot highlighted the growing consumer demand for healthy alternatives. GoodWheat pasta, made from proprietary non-GMO wheat, helps address low fiber intake among Americans. For more information, visit eatgoodwheat.com.
Arcadia Biosciences (NASDAQ: RKDA) announced the departure of CFO Pam Haley, effective January 3, 2023, with Thomas J. Schaefer stepping into the role. Schaefer, currently the company's vice president of finance and investor relations, brings over 20 years of finance experience, having previously worked in equity research and corporate finance. He has contributed to key initiatives, including the launch of GoodWheat and the Project Greenfield long-term strategy. Haley will remain in an advisory capacity during the transition.
Arcadia Biosciences (Nasdaq: RKDA) reported a Q3 2022 revenue of $1.9 million, down 21% from $2.4 million in Q3 2021. However, revenues for the first nine months of 2022 surged 94% to $9 million. The launch of GoodWheat™ Pasta contributed to growth, doubling distribution and improving gross margins to 28%. Operating expenses fell 42% year-over-year. Despite improvements, the net loss attributable to common stockholders widened to $2.9 million, compared to $2.2 million in the same period last year. The company continues to focus on streamlining operations for long-term profitability.
Arcadia Biosciences (Nasdaq: RKDA) will release its third quarter and first nine months of 2022 financial results after market close on November 10, 2022. A conference call is scheduled for 4:30 p.m. Eastern time to discuss these results and key strategic achievements. Participants can join via U.S. toll-free at +1-866-374-5140 or internationally at +1-404-400-0571, using the passcode 14010760. This session will also be available via a live webcast on the company's investor website.
Arcadia Biosciences (Nasdaq: RKDA) announced its participation in two upcoming investor conferences in September 2022. The first is the H.C. Wainwright 24th Annual Global Investment Conference, taking place from September 12-14 in New York City, where CEO Stan Jacot will present on September 13 at 5:00 p.m. ET. The second event is the Lake Street Capital Markets' 6th Annual Best Ideas Growth Conference on September 14, also in New York City. Investors can register for meetings through the respective conference websites.
Arcadia Biosciences (Nasdaq: RKDA) has completed a registered direct offering of 4,722,506 shares priced at $1.05876 per share, raising approximately $4.57 million in net proceeds. These funds will be utilized to support Project Greenfield, aimed at profitability through expanding retail for their GoodWheat high-fiber pasta and other core brands. Additionally, the company issued preferred investment options for the same number of shares with an exercise price of $0.93376, valid for five years.
Arcadia Biosciences (Nasdaq: RKDA) announced a registered direct offering of 4,722,506 shares of common stock at $1.05876 per share, totaling approximately $5 million in gross proceeds. The offering is part of a three-year initiative, Project Greenfield, aimed at expanding its GoodWheat brand and driving growth in core products. The offering, facilitated by H.C. Wainwright & Co., is set to close on or around August 16, 2022, pending usual conditions. The unregistered investment options for additional shares will also be made available, exercisable at $0.93376 per share.
Arcadia Biosciences (Nasdaq: RKDA) reported a 175% increase in revenue for Q2 2022, totaling $3.9 million, driven by successful launches of GoodWheat™ pasta and sales of Zola products. In the first half of 2022, total revenues reached $7.1 million, up from $2.2 million year-over-year. The company recognized a $2 million milestone for HB4® soybean approval in China. However, net losses narrowed to $3.8 million from $5.3 million in Q2 2021. Project Greenfield aims to drive profitability.
Arcadia Biosciences (Nasdaq: RKDA) announced that it will release its financial results for the second quarter and first half of 2022 after market close on August 11, 2022.
A conference call to discuss these results and key strategic achievements is scheduled for 4:30 p.m. Eastern time. Participants can join via U.S. toll-free dial-in at +1-866-374-5140 or international dial-in at +1-404-400-0571. A live webcast will also be available on the company’s website.
